Miansec

Mianserin Hydrochloride, the active ingredient in Miansec, is a tetracyclic antidepressant presented as an oral tablet for oral use. It is indicated for the treatment of major depressive disorder in adult patients.

GNH USA supplies Miansec as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mianserin is a tetracyclic antidepressant that modulates noradrenergic and serotonergic pathways in depressive disorders.

- Major depressive disorder: reduces depressive symptoms and improves mood. - Depressive episodes in bipolar disorder: helps stabilize depressive phases. - Anxiety associated with depression: alleviates concurrent anxiety symptoms.

Mianserin may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Dry mouth: reduced salivation causing throat discomfort. - Weight gain: increase in body weight over time. - Constipation: difficulty passing stools.

Serious or Rare Side Effects: - Agranulocytosis: severe reduction in white blood cells. - Seizures: occurrence of convulsive episodes. - Cardiac arrhythmia: irregular heart rhythm that may be life‑threatening.

Before initiating therapy, clinicians should consider several safety measures.

- Monitor blood pressure: watch for hypotensive episodes. - Assess hepatic function: evaluate liver enzymes periodically. - Evaluate suicidal ideation: screen patients for worsening mood. - Use caution in the elderly: increased sensitivity to sedative effects. - Avoid abrupt discontinuation: taper gradually to reduce withdrawal. - Store at room temperature: keep in the original pack, protect from moisture.

Mianserin can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Monoamine oxidase inhibitors: risk of hypertensive crisis. - Selective serotonin reuptake inhibitors: potential serotonin syndrome. - CNS depressants: enhanced sedation and respiratory depression.

Moderate Interactions (Monitor Closely): - Antihistamines: additive drowsiness. - Antihypertensives: possible additive hypotensive effect.